Status:
COMPLETED
Impact of Vaping Prevention Advertisements
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
National Institutes of Health (NIH)
Food and Drug Administration (FDA)
Conditions:
Vaping
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
The purpose of this randomized controlled trial is to determine whether exposure to vaping prevention advertisements (ads) reduce susceptibility to vaping among adolescents. Previous studies have been...
Detailed Description
Tobacco prevention mass media campaigns are a key tool for reducing tobacco use among adolescents. While vaping has increased greatly among adolescents, there has been a dearth of research on effectiv...
Eligibility Criteria
Inclusion
- Between ages 13-17 years old
- Be able to read and speak English
- Be able to take an online survey in English
- Be susceptible to vaping
Exclusion
- None
Key Trial Info
Start Date :
July 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 3 2021
Estimated Enrollment :
1565 Patients enrolled
Trial Details
Trial ID
NCT04836455
Start Date
July 3 2021
End Date
November 3 2021
Last Update
April 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States, 27599